IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Reviews 2005-2017

The Involvement of Retroperitoneal Lymph Nodes in Primary Serous-papillary Peritoneal Carcinoma. A Systematic Review of the Literature.
P.R. STEINHAGEN, J. SEHOULI (Berlin, Germany). Anticancer Res 31: 1387-1394, 2011.
Potential Tumor-tropic Effect of Genetically Engineered Stem Cells Expressing Suicide Enzymes to Selectively Target Invasive Cancer in Animal Models.
S.U. KIM, E.-B. JEUNG, Y.-B. KIM, M.-H. CHO, K.-C. CHOI (Vancouver, BC, Canada; Chungbuk; Seoul, South Korea). Anticancer Res 31: 1249-1258, 2011.
Body Fluid Biomarkers for Early Detection of Head and Neck Squamous Cell Carcinomas.
K.-D. LEE, H.-S. LEE, C.-H. JEON (Busan; Daegu, South Korea). Anticancer Res 31: 1161-1168, 2011.
Targeting Notch to Eradicate Pancreatic Cancer Stem Cells for Cancer Therapy.
Z. WANG, A. AHMAD, Y. LI, A.S. AZMI, L. MIELE, F.H. SARKAR (Detroit, MI; Jackson, MS, USA). Anticancer Res 31: 1105-1114, 2011.
Full Myeloablative Conditioning and an Unrelated HLA Mismatched Donor Increase the Risk for BK Virus-positive Hemorrhagic Cystitis in Allogeneic Hematopoietic Stem Cell Transplanted Patients.
T. DALIANIS, P. LJUNGMAN (Stockholm, Sweden). Anticancer Res 31: 939-944, 2011.
Influencing the Wnt Signaling Pathway in Multiple Myeloma.
Y. KIM, G. REIFENBERGER, D. LU, T. ENDO, D.A. CARSON, S.-M. GAST, K. MESCHENMOSER, M. NOWAK, I.G.H. SCHMIDT- WOLF (Bonn; Duesseldorf, Germany; La Jolla, CA, USA; Sapporo, Hokkaido, Japan). Anticancer Res 31: 725-730, 2011.
The Need for Third-line Treatment in Non-small Cell Lung Cancer: An Overview of New Options.
K.N. SYRIGOS, M.W. SAIF, E.M. KARAPANAGIOTOU, G. OIKONOMOPOULOS, F. DE MARINIS (Athens, Greece; New Haven; New York, NY, USA; Rome, Italy). Anticancer Res 31: 649-660, 2011.
Prediction of Response in Cancer Immunotherapy.
D. CHARACIEJUS, J.J.L. JACOBS, V. PASUKONIENÖ, N. KAZLAUSKAITÖ, V. DANILEVICIÜTÖ, M. MAURICAS, W. DEN OTTER (Vilnius, Lithuania; Amsterdam, The Netherlands). Anticancer Res 31: 639-648, 2011.
The Role of Pelvic Lymph Node Dissection During Radical Cystectomy for Bladder Cancer.
E. BRUNOCILLA, R. PERNETTI, G. MARTORANA (Bologna, Italy). Anticancer Res 31: 271-276, 2011.
Ectomesenchymal Chondromyxoid Tumour of the Tongue. A Review of Histological and Immunohistochemical Features.
F. ANGIERO (Monza, Italy). Anticancer Res 30: 4685-4690, 2010.
Ras Mutational Status Is a Biomarker for Resistance to EGFR Inhibitors in Colorectal Carcinoma.
W.C.M. DEMPKE, V. HEINEMANN (Riesa; Munich, Germany). Anticancer Res 30: 4673-4678, 2010.
Brivanib, A Novel Dual VEGF-R2/bFGF-R Inhibitor.
W.C.M. DEMPKE, R. ZIPPEL (Riesa, Germany). Anticancer Res 30: 4477-4484, 2010.
Poly-N-acetyl Glucosamine Gel Matrix as a Non-viral Delivery Vector for DNA-based Vaccination.
M.L. SALEM, M. DEMCHEVA, W.E. GILLANDERS, D.J. COLE, J.N. VOURNAKIS (Charleston, SC; Danvers, MA; Saint Louis, MO, USA). Anticancer Res 30: 3889-3894, 2010.
The Evolving Role of Radiofrequency Ablation Therapy of Breast Lesions.
B. SOUKUP, S. BISMOHUN, S. REEFY, K. MOKBEL (London, UK). Anticancer Res 30: 3693-3698, 2010.
Active Surveillance for Low-risk Prostate Cancer.
R. MAZZUCCHELLI, I. NESSERIS, L. CHENG, A. LOPEZ-BELTRAN, R. MONTIRONI, M. SCARPELLI (Ancona, Italy; Ioannina, Greece; Indianapolis, IN, USA; Cordoba, Spain). Anticancer Res 30: 3683-3692, 2010.
Novel Chemoradiosensitizers for Cancer Therapy.
P. PAGE, L.-X. YANG (San Francisco, CA, USA). Anticancer Res 30: 3675-3682, 2010.
Medicinal Electronomics Bricolage Design of Hypoxia-targeting Antineoplastic Drugs and Invention of Boron Tracedrugs as Innovative Future-architectural Drugs.
H. HORI, Y. UTO, E. NAKATA (Tokushima, Japan). Anticancer Res 30: 3233-3242, 2010.
Multiple Roles of the ERCC1-XPF Endonuclease in DNA Repair and Resistance to Anticancer Drugs.
K. KIRSCHNER, D.W. MELTON (Cambridge; Edinburgh, UK). Anticancer Res 30: 3223-3232, 2010.
Recovery from Immunosuppression-related Disorders in Humans and Animals by IP-PA1, An Edible Lipopolysaccharide.
T. HEBISHIMA, Y. MATSUMOTO, G. WATANABE, G.-I. SOMA, C. KOHCHI, K. TAYA, Y. HAYASHI, Y. HIROTA (Tokyo; Tokushima; Kagawa; Gifu, Japan). Anticancer Res 30: 3113-3118, 2010.
Emerging Strategies for ErbB Ligand-based Targeted Therapy for Cancer.
H. TSUJIOKA, F. YOTSUMOTO, K. SHIROTA, S. HORIUCHI, T. YOSHIZATO, M. KUROKI, S. MIYAMOTO (Fukuoka, Japan). Anticancer Res 30: 3107-3112, 2010.
Validation of Blood Testing for K-ras Mutations in Colorectal and Pancreatic Cancer.
M. ROGOSNITZKY, R. DANKS (Telz Stone, Israel; Steep, UK). Anticancer Res 30: 2943-2948, 2010.
Liver Regeneration and its Impact on Post-hepatectomy Metastatic Tumour Recurrence.
K.A. PASCHOS, N.C. BIRD (Sheffield, UK). Anticancer Res 30: 2161-2170, 2010.
An Overview of Nanotechnology-based Functional Proteomics for Cancer and Cell Cycle Progression.
C. NICOLINI, E. PECHKOVA (Genoa; Rome, Italy). Anticancer Res 30: 2073- 2080, 2010.
On the Origin and Growth of Gliomas.
D. SCHIFFER, L. ANNOVAZZI, V. CALDERA, M. MELLAI (Turin, Italy). Anticancer Res 30: 1977-1998, 2010.
Metabolism in Cancer Patients.
J. ARENDS (Freiburg, Germany). Anticancer Res 30: 1863- 1868, 2010.
Evidence-based Complementary Oncology: Innovative Approaches to Optimise Standard Therapy Strategies.
J. BEUTH (Cologne, Germany). Anticancer Res 30: 1767-1772, 2010.
Clear Cell Carcinoma of the Endometrium: A Biological and Clinical Enigma.
A. GADDUCCI, S. COSIO, N. SPIRITO, L. CIONINI (Pisa, Italy). Anticancer Res 30: 1327-1334, 2010.
Erlotinib in the Treatment of Non-small Cell Lung Cancer: Current Status and Future Developments.
C. GRIDELLI, P. MAIONE, M.A. BARESCHINO, C. SCHETTINO, P.C. SACCO, R. AMBROSIO, V. BARBATO, M. FALANGA, A. ROSSI (Avellino, Italy). Anticancer Res 30: 1301- 1310, 2010.
Gamma-glutamyltransferase of Cancer Cells at the Crossroads of Tumor Progression, Drug Resistance and Drug Targeting.
A. CORTI, M. FRANZINI, A. PAOLICCHI, A. POMPELLA (Pisa, Italy). Anticancer Res 30: 1169-1182, 2010.
Role of Regulatory T-cells in H. pylori-induced Gastritis and Gastric Cancer.
A. KANDULSKI, P. MALFERTHEINER, T. WEX (Magdeburg, Germany). Anticancer Res 30: 1093-1104, 2010.
Neoadjuvant Chemotherapy in Barrett's Carcinoma – Prognosis and Response Prediction.
M. SCHAUER, W.T. KNOEFEL (Duesseldorf, Germany). Anticancer Res 30: 1065-1070, 2010.
Environmental Oestrogens and Breast Cancer: Evidence for Combined Involvement of Dietary, Household and Cosmetic Xenoestrogens.
P.D. DARBRE, A.K. CHARLES (Reading, UK). Anticancer Res 30: 815-828, 2010.
Association Between Birt Hogg Dubé Syndrome and Cancer Predisposition.
Reducing Anastomotic Leakage in Oncologic Colorectal Surgery: An Evidence-based Review.
M.A. BOCCOLA, J. LIN, W.M. ROZEN, Y.-H. HO (Queensland, Australia). Anticancer Res February 30: 601-608, 2010.
Epithelial–Stromal Interaction in Squamous Cell Epithelium-derived Tumors: An Important New Player in the Control of Tumor Biological Properties.
J. PLZAK, L. LACINA, M. CHOVANEC, B. DVORANKOVA, P. SZABO, Z. CADA, K. SMETANA, Jr. (Prague, Czech Republic). Anticancer Res 30: 455-462, 2010.
Lessons from Immune Responses and Vaccines against Murine Polyomavirus Infection and Polyomavirus-induced Tumours Potentially Useful for Studies on Human Polyomaviruses.
T. RAMQVIST, T. DALIANIS (Stockholm, Sweden). Anticancer Res 30: 279-284, 2010.
A Novel Strategy by Cryoablation for Advanced Hepatoma.
S. OSADA, K. YOSHIDA, S. SAJI (Gifu, Japan). Anticancer Res 29: 5203-5210, 2009.
Chemotherapy for Glioblastoma: Current Treatment and Future Perspectives for Cytotoxic and Targeted Agents.
G. MINNITI, R. MUNI, G. LANZETTA, P. MARCHETTI, R. MAURIZI ENRICI (Rome; Pozzilli (IS), Italy). Anticancer Res 29: 5171-5184, 2009.
Pathology of Prostate Cancer and Focal Therapy (‘Male Lumpectomy’).
R. MAZZUCCHELLI, M. SCARPELLI, L. CHENG, A. LOPEZ-BELTRAN, A.B. GALOSI, Z. KIRKALI, R. MONTIRONI (Ancona, Italy; Indianapolis, IN, USA; Cordoba, Spain; Izmir, Turkey). Anticancer Res 29: 5155-5162, 2009.
L1-CAM as a Target for Treatment of Cancer with Monoclonal Antibodies.
U.H. WEIDLE, D. EGGLE, S. KLOSTERMANN (Penzberg, Germany). Anticancer Res 29: 4919-4932, 2009.
Efficacy of Ligand-based Targeting for the EGF System in Cancer.
F. YOTSUMOTO, A. SANUI, T. FUKAMI, K. SHIROTA, S. HORIUCHI, H. TSUJIOKA, T. YOSHIZATO, M. KUROKI, S. MIYAMOTO (Fukuoka, Japan). Anticancer Res 29: 4879-4886, 2009.
Improvement of Allergic Dermatitis via Regulation of the Th1/Th2 Immune System Balance by Macrophages Activated with Lipopolysaccharide Derived from Pantoea agglomerans (IP-PA1).
A. YOSHIDA, C. KOHCHI, H. INAGAWA, T. NISHIZAWA, G.-I. SOMA (Tokushima; Kagawa; Chiba; Yamaguchi, Japan). Anticancer Res 29: 4867-4870, 2009.
Intestinal Macrophages Involved in the Homeostasis of the Intestine Have the Potential for Responding to LPS.
N. YOSHIOKA, Y. TANIGUCHI, A. YOSHIDA, K. NAKATA, T. NISHIZAWA, H. INAGAWA, C. KOHCHI, G.-I. SOMA (Tokushima; Kagawa; Okayama; Yamaguchi; Chiba, Japan). Anticancer Res 29: 4861-4866, 2009.
Mechanism for Maintaining Homeostasis in the Immune System of the Intestine.
Y. TANIGUCHI, N. YOSHIOKA, K. NAKATA, T. NISHIZAWA, H. INAGAWA, C. KOHCHI, G.-I. SOMA (Tokushima; Kagawa; Okayama; Yamaguchi; Chiba, Japan). Anticancer Res 29: 4855- 4860, 2009.
Anti-glioma Therapy with Temozolomide and Status of the DNA-Repair Gene MGMT.
T. FUKUSHIMA, H. TAKESHIMA, H. KATAOKA (Miyazaki, Japan). Anticancer Res 29: 4845-4854, 2009.
Tumour Biology: Tumour-associated Inflammation versus Antitumor Immunity.
B. MÜLLERHÜBENTHAL, M. AZEMAR, D. LORENZEN, M. HUBER, M.A FREUDENBERG, C. GALANOS, C. UNGER, B. HILDENBRAND (Freiburg; Duderstadt; Aachen, Germany). Anticancer Res 29: 4795-4806, 2009.
Immunological Similarities between Cancer and Chronic Fatigue Syndrome: The Common Link to Fatigue?
M. MEEUS, W. MISTIAEN, L. LAMBRECHT, J. NIJS (Antwerp; Brussels, Ghent, Belgium). Anticancer Res 29: 4717-4726, 2009.
Cancer Nanotargeted Radiopharmaceuticals for Tumor Imaging and Therapy.
G. TING, C.-H. CHANG, H.-E. WANG (Miaoli; Taoyuan; Taipei, Taiwan, ROC). Anticancer Res 29: 4107-4118, 2009.
Telomeres and Telomerase in Sarcomas.
T. MATSUO, S. SHIMOSE, T. KUBO, J. FUJIMORI, Y. YASUNAGA, M. OCHI (Hiroshima, Japan). Anticancer Res 29: 3833-3836, 2009.
Role of MGMT in Tumor Development, Progression, Diagnosis, Treatment and Prognosis.
S. SHARMA, F. SALEHI, B.W. SCHEITHAUER, F. ROTONDO, L.V. SYRO, K. KOVACS (Toronto, ON, Canada; Rochester, NY, USA; Medellin, Colombia). Anticancer Res 29: 3759-3768, 2009.
Page: 1 2 3 4 5 6 ... 7 8 9 10 11 
Custom Tables Plugin 05a1a29bdcae7b12229e651a9fd48b11

IMPORTANT NOTE: You may submit your article only through our online submission system